121 related articles for article (PubMed ID: 3827882)
21. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
Fujibayashi S; Wenger DA
Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
[TBL] [Abstract][Full Text] [Related]
22. Accelerated transfer of neutral glycosphingolipids and ganglioside GM1 by a purified lipid transfer protein.
Bloj B; Zilversmit DB
J Biol Chem; 1981 Jun; 256(12):5988-91. PubMed ID: 6894595
[TBL] [Abstract][Full Text] [Related]
23. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
24. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
25. Activator protein for the degradation of globotriaosylceramide by human alpha-galactosidase.
Gärtner S; Conzelmann E; Sandhoff K
J Biol Chem; 1983 Oct; 258(20):12378-85. PubMed ID: 6313655
[TBL] [Abstract][Full Text] [Related]
26. Accumulation of globotriaosylceramide in a case of leiomyosarcoma.
Li SC; Kundu SK; Degasperi R; Li YT
Biochem J; 1986 Dec; 240(3):925-7. PubMed ID: 3827883
[TBL] [Abstract][Full Text] [Related]
27. Substrate binding properties of the human liver hexosaminidase A activator protein.
Hechtman P; Isaacs C; Smith-Jones L
Can J Biochem Cell Biol; 1985 Aug; 63(8):830-8. PubMed ID: 2933135
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
29. Synopsis: gangliosidoses.
Schwab ME; Vassella F
Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
[TBL] [Abstract][Full Text] [Related]
30. Characterization of neutral and acidic glycosphingolipids in brains of two patients with GM1 gangliosidosis type 1 and type 2.
Ishikawa Y; Makita A; Minami R
J Neurochem; 1985 Apr; 44(4):1100-6. PubMed ID: 3919156
[TBL] [Abstract][Full Text] [Related]
31. Modulation of phospholipase A2 activity by neutral and anionic glycosphingolipids in monolayers.
Bianco ID; Fidelio GD; Maggio B
Biochem J; 1989 Feb; 258(1):95-9. PubMed ID: 2930519
[TBL] [Abstract][Full Text] [Related]
32. Neutral glycosphingolipids of murine myeloma cells and helper, cytolytic, and suppressor T lymphocytes.
Kniep B; Hünig TR; Fitch FW; Heuer J; Kölsch E; Mühlradt PF
Biochemistry; 1983 Jan; 22(2):251-5. PubMed ID: 6218821
[TBL] [Abstract][Full Text] [Related]
33. Glycolipid-binding proteins.
Sasaki T
Chem Phys Lipids; 1985 Aug; 38(1-2):63-77. PubMed ID: 4064224
[TBL] [Abstract][Full Text] [Related]
34. Quantification of mRNAs encoding proteins of the glycosphingolipid catabolism in mouse models of GM2 gangliosidoses and sphingolipid activator protein precursor (prosaposin) deficiency.
Potratz A; Hüttler S; Bierfreund U; Proia RL; Suzuki K; Sandhoff K
Biochim Biophys Acta; 2000 Nov; 1502(3):391-7. PubMed ID: 11068181
[TBL] [Abstract][Full Text] [Related]
35. Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon.
Tamaru T; Fujibayashi S; Brown WR; Wenger DA
Histochemistry; 1986; 86(2):195-200. PubMed ID: 3028990
[TBL] [Abstract][Full Text] [Related]
36. Effect of the different supramolecular organization on the uptake and metabolization of exogenous GM1 ganglioside by human fibroblasts.
Giglioni A; Chigorno V; Pitto M; Valsecchi M; Palestini P; Ghidoni R
Chem Phys Lipids; 1990 Aug; 55(2):207-13. PubMed ID: 2090360
[TBL] [Abstract][Full Text] [Related]
37. Only sphingolipid activator protein B (SAP-B or saposin B) stimulates the degradation of globotriaosylceramide by recombinant human lysosomal alpha-galactosidase in a detergent-free liposomal system.
Kase R; Bierfreund U; Klein A; Kolter T; Itoh K; Suzuki M; Hashimoto Y; Sandhoff K; Sakuraba H
FEBS Lett; 1996 Sep; 393(1):74-6. PubMed ID: 8804427
[TBL] [Abstract][Full Text] [Related]
38. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
39. Binding specificity of Lactobacillus to glycolipids.
Yamamoto K; Miwa T; Taniguchi H; Nagano T; Shimamura K; Tanaka T; Kumagai H
Biochem Biophys Res Commun; 1996 Nov; 228(1):148-52. PubMed ID: 8912650
[TBL] [Abstract][Full Text] [Related]
40. Molecular parameters and physical state of neutral glycosphingolipids and gangliosides in monolayers at different temperatures.
Fidelio GD; Maggio B; Cumar FA
Biochim Biophys Acta; 1986 Jan; 854(2):231-9. PubMed ID: 3942728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
